E-Book | April 14, 2022

Synthetic Control Arm®: The Regulatory Grade External Control Arm To Power Your Clinical Trials

Source: Medidata AI

Randomized Control Trials (RCTs) are the gold standard for evaluating the safety and efficacy of new treatments. However, in some circumstances, maintaining a concurrent control arm is not feasible.

External Control Arms (ECAs) can help sponsors overcome recruitment challenges in trials with small patient populations. They can also provide supplementary data, beyond what a clinical trial itself can produce, to bolster trial results when necessary.

This eBook provides guidance on the increasing role of ECAs, the differences between control groups built using real world data (RWD) and a Synthetic Control Arm (SCA ® ) containing historical clinical trial data (HCTD), and the successful impact of SCA on clinical trial design decisions and regulatory conversations.

To learn more about Medidata Acorn AI, visit their Clinical Leader page.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader